Globela Pharma
- Company typePrivate
- Founded2006
- HeadquartersSachin, India
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Globela Pharma does
Globela Pharma Pvt Ltd is a vertically integrated pharmaceutical manufacturer incorporated in Gujarat, India in 2006 as a private limited company (CIN U24230GJ2006PTC047699). The company operates end-to-end capabilities spanning R&D, active pharmaceutical ingredients (APIs) and intermediates, semi-finished and finished dosage formulations, and contract development and manufacturing (CDMO) and contract research and manufacturing services (CRAMS). Its manufacturing infrastructure includes DSIR-approved R&D units and EU GMP-certified facilities specialized for cytotoxic oncology formulations and cephalosporin antibiotics. Globela serves global pharmaceutical innovator companies seeking regulated-market supply (US, EU, Japan) as well as healthcare distributors and providers across more than 50 countries, with corporate headquarters and primary manufacturing located in the GIDC Sachin industrial area of Surat.
Globela Pharma firmographics
Firmographics- Name
- Globela Pharma
- Legal name
- Globela Pharma Pvt Ltd
- Website
- https://globelapharma.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Globela Pharma industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (32541), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
- akta.pro secondary industries
- Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM), Drug Substance–Drug Product Integrated CDMO (HLAGABAG)
Keywords
Where Globela Pharma is headquartered
LocationHeadquarters
- HQ city
- Sachin
- HQ country
- India
- HQ region
- Asia
Offices1 record
Markets served
Globela Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- CDMO Services: Contract Development and Manufacturing Organization services for oral solid dosages (OSD) and specialized cytotoxic formulations. Includes end-to-end development and commercial manufacturing, regulatory dossier support, and submission-ready documentation for US, EU, and Japan markets.
- CRAMS Services: Contract Research and Manufacturing Services supporting global innovator companies in advancing Novel Chemical Entities (NCEs) from discovery to commercialization. Includes synthetic route scouting, process development, analytical method development, and CMC documentation for filings.
- Finished Dosage Formulations (FDF): Manufacturing and sale of finished pharmaceutical products including tablets, capsules, dry syrups, effervescent tablets, and pellets across multiple therapeutic areas including Oncology, Anti-Malarial, Anti-Retroviral, Cardiovascular, Anti-Diabetics, and Antibiotics.
- API and Intermediates: Active Pharmaceutical Ingredients including vitamin C and derivatives, and pharmaceutical intermediates for Proton Pump Inhibitors (PPI). Manufacturing since 1992 through Globela Industries Group.
- Technology Transfer Services: Technology transfer services for APIs, advanced intermediates, and finished dosage forms focusing on process integrity, regulatory compliance, and manufacturing readiness.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Globela Pharma product offering
Product offeringCore offering
Globela Pharma is a vertically integrated pharmaceutical formulation manufacturer that produces finished dosage formulations (tablets, capsules, dry syrups, effervescent tablets, pellets), DC granules and intermediates, active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The company also provides CDMO (Contract Development and Manufacturing Organization) and CRAMS (Contract Research and Manufacturing Services) for global innovator companies serving regulated markets including the US, EU, and Japan, with specialized capabilities in Oncology (cytotoxic formulations) and Cephalosporins.
Product overview
Globela Pharma is a vertically integrated pharmaceutical manufacturer offering end-to-end capabilities across the pharma value chain. The portfolio includes Finished Dosage Formulations (FDF) such as tablets, capsules, dry syrups, and effervescent tablets; DC Granules and Pellets intermediates; Active Pharmaceutical Ingredients (API) and Intermediates; and Contract Research and Manufacturing Services (CRAMS), Contract Development & Manufacturing Organization (CDMO), and Technology Transfer Services. The company specializes in therapeutic areas including Oncology (particularly oral solid cytotoxic formulations), Cephalosporins, ARV, and various other therapeutic categories spanning Gastroenterology, Anti-Infectives, Analgesics, Cardiovascular, Anti-Diabetics, and Nephrology. Services are complemented by DSIR-approved R&D capabilities and regulatory expertise across global markets.
Differentiator
Problem solved
Functional benefit
Products and services
- Finished Dosage Formulations (FDF)
Quantifiable outcome
- Delivering to 50+ countries globally with high-quality, affordable pharmaceutical solutions
- +1 more outcomes
Companies that use Globela Pharma
Customer profileSegments3 records
Ideal customer profiles3 records
Globela Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Globela Pharma partnerships and signals
Strategic signalScale indicators5 records
Recent moves5 records
Expansion highlights6 records
Globela Pharma competitors and assessment
Company assessmentDirect peers
- Divis Laboratories: Indian API and intermediates manufacturer with growing CDMO capabilities serving global innovator pharma. Directly comparable as a vertically integrated Indian pharma CDMO serving regulated markets.
- Syngene International: India-based CRAMS and CDMO providing end-to-end contract research and manufacturing services to global pharma. Closely analogous business model in CRAMS and oncology-adjacent capabilities.
- Piramal Pharma Solutions: Indian CDMO offering development and manufacturing services across sterile, oral solid, and complex formulations including HPAPI/oncology. Highly comparable services portfolio and customer profile (global innovator pharma).
- Centrient Pharmaceuticals: Indian-origin API and intermediates manufacturer with vertical integration into finished dosages. Comparable API-driven model with regulated market certifications serving global generics customers.
Broad incumbents
- Aurobindo Pharma: Large Indian generics and API manufacturer with vertically integrated operations serving 150+ countries. Comparable vertically integrated pharma model at much larger scale; dominant Indian peer in finished dosages and oncology supply.
- Dr. Reddy's Laboratories: Indian pharma major with API, generics, and emerging CDMO services targeting regulated markets. Comparable Indian-headquartered manufacturer with API + finished dosage integration.
- Cipla: India-headquartered global pharma manufacturer with strong ARV, respiratory, and oncology portfolios. Comparable across FDF manufacturing, ARV category, and global (50+ country) distribution.
- Lupin Limited: Indian pharmaceutical manufacturer with API + finished formulations across multiple therapeutic areas including Cephalosporins. Directly comparable in Cephalosporin FDF and global generics distribution.
Emerging players
- Aizant Drug Research Solutions: Indian formulation development and manufacturing company offering CDMO services for OSD and specialty products. Closely comparable mid-sized Indian CDMO with similar therapeutic breadth.
Regional players
- Neogen Chemicals: Indian manufacturer of APIs and intermediates (including for PPIs and vitamins). Directly comparable on the API/intermediates product line and PPI/vitamin C manufacturing origin.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Globela Pharma social profiles
Digital presenceGlobela Pharma compliance and trust
Trust signalCompliance5 records
Globela Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Globela Pharma leadership team
Management profileNumber of profiles
Profiles1 record
Globela Pharma subsidiaries and ownership
Company hierarchySubsidiaries1 record
Globela Pharma funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Globela Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Globela Pharma
What does Globela Pharma do?
Globela Pharma is a vertically integrated pharmaceutical formulation manufacturer that produces finished dosage formulations (tablets, capsules, dry syrups, effervescent tablets, pellets), DC granules and intermediates, active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The company also provides CDMO (Contract Development and Manufacturing Organization) and CRAMS (Contract Research and Manufacturing Services) for global innovator companies serving regulated markets including the US, EU, and Japan, with specialized capabilities in Oncology (cytotoxic formulations) and Cephalosporins.
Is Globela Pharma a public or private company?
Globela Pharma is a private company. It is classified as private equity controlled and is currently operating.
When was Globela Pharma founded?
Globela Pharma was founded in 2006. It employs 101 to 250 people.
Where is Globela Pharma based?
Globela Pharma is headquartered in Sachin, India, in the Asia region.
How does Globela Pharma make money?
Five revenue lines are on record. CDMO Services are the primary driver. The others are CRAMS Services, finished Dosage Formulations (FDF), API and Intermediates and technology Transfer Services.
Who are Globela Pharma's main competitors?
Direct peers on record are Divis Laboratories, Syngene International, Piramal Pharma Solutions and Centrient Pharmaceuticals. Broad incumbents are Aurobindo Pharma, Dr. Reddy's Laboratories, Cipla and Lupin Limited. Aizant Drug Research Solutions is listed as an emerging player. Neogen Chemicals is listed as a regional player.
Does Globela Pharma have an API?
No public API is recorded for Globela Pharma.
What industry is Globela Pharma in?
Globela Pharma's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGAHAM, Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC). Its NAICS code is 325412 and its SIC code is 2834.